Position
Fidelity in Kyverna Therapeutics, Inc.
Back to the book · All holders of KYTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.9K$8.63 → $8.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.98K | $65.6K | — | — | — | 0.0% |
| Q1 2026 | 6.81K | $58.8K | $8.63 | −$5.24K | −$1.55K | 0.0% |
| Q2 2026 | 96.1K | $855.8K | $8.91 | $1.9K | $795.1K | 0.0% |